ArticleDepression and anxiety2010
Subtyping social anxiety disorder in developed and developing countries.
Article in Depression and anxiety, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 64 citations in OpenAlex.
- A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trial.BMC research notes · 2013Trial
- The psychometric validity and reliability of the DSM-5 Severity Measure for Social Anxiety Disorder in a Turkish adult clinical population.Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi · 2026Article
- Alterations in cerebral resting state functional connectivity associated with social anxiety disorder and early life adversities.Translational psychiatry · 2025Article
- Measuring the neglected anxiety disorder: validation of the social anxiety spectrum-short version (SHY-SV) questionnaire.BMC psychiatry · 2023Article
- Intrinsic functional connectivity in families genetically enriched for social anxiety disorder - an endophenotype study.EBioMedicine · 2021Article
- A systematic review of the Trier Social Stress Test methodology: Issues in promoting study comparison and replicable research.Neurobiology of stress · 2020Review
- The Neural Correlates of Face-Voice-Integration in Social Anxiety Disorder.Frontiers in psychiatry · 2020Article
- Commentary: Gray Matter Structural Alterations in Social Anxiety Disorder: A Voxel-Based Meta-Analysis.Frontiers in psychiatry · 2019Article
- Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy.Metabolic brain disease · 2018Article
- Epidemiology of anxiety disorders: from surveys to nosology and back.Dialogues in clinical neuroscience · 2017Review
- Voxel-based morphometry multi-center mega-analysis of brain structure in social anxiety disorder.NeuroImage. Clinical · 2017Article
- The fear of being laughed at as additional diagnostic criterion in social anxiety disorder and avoidant personality disorder?PloS one · 2017Article
- Recent Insight Into the Subtypes of Social Anxiety Disorder.Current psychiatry reports · 2016Review
- Neuroendocrine models of social anxiety disorder.Dialogues in clinical neuroscience · 2015Review
- fMRI Study of Social Anxiety during Social Ostracism with and without Emotional Support.PloS one · 2015Article
- Social anxiety disorder and the psychobiology of self-consciousness.Frontiers in human neuroscience · 2015Review
- Dimensional assessment of DSM-5 social anxiety symptoms among university students and its relationship with functional impairment.Neuropsychiatric disease and treatment · 2014Article
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.BMC psychiatry · 2014Review
- Article
- The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma.Current psychiatry reports · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 20 institutions in 16 countries.
Funding
Abstract
backgroundAlthough social anxiety disorder (SAD) is classified in the fourth edition of The Diagnostic and Statistical Manual (DSM-IV) into generalized and non-generalized subtypes, community surveys in Western countries find no evidence of disjunctions in the dose-response relationship between number of social fears and outcomes to support this distinction. We aimed to determine whether this holds across a broader set of developed and developing countries, and whether subtyping according to number of performance versus interactional fears would be more useful.
methodsThe World Health Organization's World Mental Health Survey Initiative undertook population epidemiological surveys in 11 developing and 9 developed countries, using the Composite International Diagnostic Interview to assess DSM-IV disorders. Fourteen performance and interactional fears were assessed. Associations between number of social fears in SAD and numerous outcomes (age-of-onset, persistence, severity, comorbidity, treatment) were examined. Additional analyses examined associations with number of performance fears versus number of interactional fears.
resultsLifetime social fears are quite common in both developed (15.9%) and developing (14.3%) countries, but lifetime SAD is much more common in the former (6.1%) than latter (2.1%) countries. Among those with SAD, persistence, severity, comorbidity, and treatment have dose-response relationships with number of social fears, with no clear nonlinearity in relationships that would support a distinction between generalized and non-generalized SAD. The distinction between performance fears and interactional fears is generally not important in predicting these same outcomes.
conclusionNo evidence is found to support subtyping SAD on the basis of either number of social fears or number of performance fears versus number of interactional fears.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.